Total Payments
$580,881
2023 Payments
$32.28
Companies
19
Transactions
630
Medicare Patients
1,272
Medicare Billing
$168,370
Payment Breakdown by Category
Other$349,546 (60.2%)
Consulting$129,739 (22.3%)
Travel$68,148 (11.7%)
Research$19,950 (3.4%)
Food & Beverage$13,272 (2.3%)
Education$226.07 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $349,546 | 158 | 60.2% |
| Consulting Fee | $129,739 | 39 | 22.3% |
| Travel and Lodging | $68,148 | 181 | 11.7% |
| Unspecified | $19,950 | 4 | 3.4% |
| Food and Beverage | $13,272 | 238 | 2.3% |
| Education | $226.07 | 10 | 0.0% |
Payments by Type
General
$560,931
626 transactions
Research
$19,950
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $142,152 | 165 | $0 (2019) |
| ABBVIE INC. | $83,115 | 97 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $76,586 | 53 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $50,628 | 46 | $0 (2018) |
| Celgene Corporation | $49,300 | 61 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $46,693 | 56 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $44,725 | 56 | $0 (2023) |
| Amgen Inc. | $21,878 | 27 | $0 (2023) |
| GENZYME CORPORATION | $21,272 | 21 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $19,819 | 17 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $32.28 | 2 | Novartis Pharmaceuticals Corporation ($16.46) |
| 2022 | $42,109 | 34 | ABBVIE INC. ($25,601) |
| 2021 | $29,030 | 38 | Amgen Inc. ($12,226) |
| 2020 | $31,895 | 25 | AbbVie Inc. ($13,136) |
| 2019 | $93,600 | 114 | AbbVie, Inc. ($17,066) |
| 2018 | $191,711 | 211 | Lilly USA, LLC ($105,621) |
| 2017 | $192,503 | 206 | E.R. Squibb & Sons, L.L.C. ($35,778) |
All Payment Transactions
630 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/15/2023 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Inflammation | ||||||
| 03/09/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Dermatology | ||||||
| 12/27/2022 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2022 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2022 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $7,700.00 | General |
| 10/07/2022 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2022 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2022 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| 09/26/2022 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2022 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $1,179.55 | General |
| 09/26/2022 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $296.06 | General |
| 09/22/2022 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $478.61 | General |
| 09/22/2022 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $470.00 | General |
| 09/22/2022 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $349.10 | General |
| 09/22/2022 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $128.60 | General |
| 09/22/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.92 | General |
| 09/21/2022 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $652.50 | General |
| 09/21/2022 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $469.79 | General |
| 09/21/2022 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $375.00 | General |
| 09/21/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $104.16 | General |
| Category: IMMUNOLOGY | ||||||
| 09/21/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $73.56 | General |
| 09/08/2022 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2022 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/01/2022 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $810.00 | General |
| Category: Inflammation | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized, Placebo-Controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Multiple Doses of BMS-986165 in Subjects With Active Psoriatic Arthritis (PsA) | E.R. Squibb & Sons, L.L.C. | $11,550 | 3 |
| A Randomized, Placebo-Controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Multiple Doses of BMS-986165 in Subjects With Active Psoriatic Arthritis PsA | E.R. Squibb & Sons, L.L.C. | $8,400 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 32 | 33 | $16,500 | $2,413 |
| 2022 | 5 | 255 | 318 | $184,230 | $36,277 |
| 2021 | 9 | 540 | 721 | $304,150 | $78,129 |
| 2020 | 7 | 445 | 560 | $214,975 | $51,551 |
Total Patients
1,272
Total Services
1,632
Medicare Billing
$168,370
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 33 | $16,500 | $2,413 | 14.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 185 | $92,500 | $19,415 | 21.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 94 | 94 | $72,850 | $12,887 | 17.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $12,000 | $2,467 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 16 | $6,000 | $1,128 | 18.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $880.00 | $380.16 | 43.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 184 | 319 | $123,050 | $35,085 | 28.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 196 | 196 | $109,180 | $28,037 | 25.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 49 | 53 | $29,150 | $6,506 | 22.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 20 | $10,775 | $3,027 | 28.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 38 | 70 | $14,000 | $2,419 | 17.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 15 | $4,125 | $1,118 | 27.1% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 14 | 16 | $9,413 | $1,000 | 10.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 14 | $3,990 | $855.14 | 21.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 16 | 18 | $467.10 | $81.63 | 17.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 178 | 279 | $97,650 | $25,210 | 25.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 170 | 170 | $90,950 | $21,539 | 23.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 23 | 24 | $13,200 | $2,955 | 22.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 23 | 31 | $6,200 | $1,116 | 18.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 11 | $2,475 | $430.45 | 17.4% |
| 93005 | Routine electrocardiogram (ekg) with tracing using at least 12 leads | Office | 2020 | 27 | 27 | $4,050 | $223.56 | 5.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 13 | 18 | $450.00 | $77.15 | 17.1% |
About Dr. Joseph Markenson, M.D
Dr. Joseph Markenson, M.D is a Specialist healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164485637.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Markenson, M.D has received a total of $580,881 in payments from pharmaceutical and medical device companies, with $32.28 received in 2023. These payments were reported across 630 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($349,546).
As a Medicare-enrolled provider, Markenson has provided services to 1,272 Medicare beneficiaries, totaling 1,632 services with total Medicare billing of $168,370. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location New York, NY
- Active Since 04/07/2006
- Last Updated 03/31/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164485637
Products in Payments
- Otezla (Drug) $70,982
- TALTZ (Drug) $48,345
- COSENTYX (Biological) $44,709
- KEVZARA SARILUMAB INJECTION (Biological) $37,904
- STELARA (Biological) $33,414
- RINVOQ (Biological) $24,728
- ORENCIA (Biological) $24,698
- KEVZARA (Biological) $15,525
- KEVZARA (Drug) $14,537
- SIMPONI ARIA (Biological) $14,335
- RINVOQ (Drug) $11,636
- Humira (Biological) $11,023
- Zilretta (Drug) $10,849
- Rinvoq (Biological) $8,036
- Rituxan (Biological) $6,200
- RENFLEXIS (Biological) $2,065
- OLUMIANT (Drug) $1,575
- HUMIRA (Biological) $1,500
- XELJANZ (Drug) $72.92
- EVENITY (Biological) $61.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in New York
Dr. Eric Rose, M.d, M.D
Specialist — Payments: $4.9M
Specialist $4.9M
Dr. Baron Lonner, M.d, M.D
Specialist — Payments: $2.9M
Specialist $2.9M
Dr. Richard Spaide, Md, MD
Specialist — Payments: $1.7M
Specialist $1.7M
Dr. Marla Dubinsky, M.d, M.D
Specialist — Payments: $1.6M
Specialist $1.6M
Mrs. Naomi Nakao, M.d, M.D
Specialist — Payments: $1.1M
Specialist $1.1M
Dr. Janice Dutcher, M.d, M.D
Specialist — Payments: $994,054
Specialist $994,054